• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor.

作者信息

Leroy L, Lafarge X, Blouin L, Bijou F, Durrieu F, Olivier E, Le Moulec S

机构信息

Medical Oncology Department, Bergonie Institute, Bordeaux, France.

Inserm Unit 1035, EFS, Bordeaux, France.

出版信息

Ann Oncol. 2018 Feb 1;29(2):514-515. doi: 10.1093/annonc/mdx693.

DOI:10.1093/annonc/mdx693
PMID:29088313
Abstract
摘要

相似文献

1
A fatal allo- and immune-mediated thrombocytopenia with a PD-L1 inhibitor.一种由程序性死亡受体配体1（PD-L1）抑制剂引起的致命性同种免疫介导的血小板减少症。
Ann Oncol. 2018 Feb 1;29(2):514-515. doi: 10.1093/annonc/mdx693.
2
Isolated Hypogonadotropic Hypogonadism Secondary to Anti-Programmed Death Ligand 1 Inhibitor.抗程序性死亡配体1抑制剂继发的孤立性低促性腺激素性性腺功能减退
J Thorac Oncol. 2019 Jul;14(7):e147-e148. doi: 10.1016/j.jtho.2019.02.028.
3
Is immune thrombocytopenic purpura (ITP) due to natural antibodies specific to platelets?免疫性血小板减少性紫癜（ITP）是由针对血小板的天然抗体引起的吗？
Eur J Haematol. 1996 Mar;56(3):178-80. doi: 10.1111/j.1600-0609.1996.tb01339.x.
4
Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia.与自身免疫性血小板减少症相关的异常细胞免疫机制。
Transfus Med Rev. 1995 Oct;9(4):327-38. doi: 10.1016/s0887-7963(05)80080-x.
5
[Platelet antigens, antibodies and related clinical conditions].[血小板抗原、抗体及相关临床情况]
Sangre (Barc). 1991 Oct;36(5):395-415.
6
HIT and run: heparin's unusual immune response.“打了就跑”：肝素不同寻常的免疫反应。
Blood. 2012 Nov 15;120(20):4119-20. doi: 10.1182/blood-2012-09-455097.
7
Characterization of novel platelet and endothelial cell target antigens in a family with genetic susceptibility to autoimmunity.对一个具有自身免疫遗传易感性家族中新型血小板和内皮细胞靶抗原的特征分析。
Am J Hematol. 1991 Dec;38(4):293-303. doi: 10.1002/ajh.2830380408.
8
Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura.慢性免疫性血小板减少性紫癜中的自身抗体和自身抗原。
Semin Hematol. 2000 Jul;37(3):239-48. doi: 10.1016/s0037-1963(00)90102-1.
9
[Determination of antigens of anti-thrombocyte antibodies in patients with different forms of thrombocytopenia].[不同形式血小板减少症患者抗血小板抗体抗原的测定]
Biull Eksp Biol Med. 1998 May;125(5):596-600.
10
Platelet autoantibodies in immune thrombocytopenic purpura.免疫性血小板减少性紫癜中的血小板自身抗体。
Transfus Sci. 1998 Sep;19(3):237-44. doi: 10.1016/s0955-3886(98)00037-x.

引用本文的文献

1
Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications.免疫治疗相关的止血异常：出血和血栓形成并发症。
Ann Hematol. 2025 Jul;104(7):3537-3551. doi: 10.1007/s00277-025-06482-z. Epub 2025 Jul 1.
2
Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization.度伐利尤单抗诱导的免疫性血小板减少症在接受钇-90放射性栓塞治疗的晚期胆管癌患者中的情况
Case Rep Oncol. 2024 Oct 18;17(1):1183-1193. doi: 10.1159/000541550. eCollection 2024 Jan-Dec.
3
Successful Treatment of Steroid-Refractory Immune Thrombocytopenia in a Patient Developing Multiple Myeloma While on Immune Checkpoint Inhibitor Therapy for Lung Cancer: A Case Report.
一名肺癌患者在接受免疫检查点抑制剂治疗期间发生多发性骨髓瘤，成功治疗类固醇难治性免疫性血小板减少症：病例报告
J Blood Med. 2024 Jun 21;15:285-290. doi: 10.2147/JBM.S468921. eCollection 2024.
4
Achilles' Heel of currently approved immune checkpoint inhibitors: immune related adverse events.目前批准的免疫检查点抑制剂的阿喀琉斯之踵：免疫相关不良事件。
Front Immunol. 2024 Feb 12;15:1292122. doi: 10.3389/fimmu.2024.1292122. eCollection 2024.
5
Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.免疫介导的血小板减少症在非小细胞肺癌患者放化疗后使用度伐鲁单抗诱导：病例报告。
Thorac Cancer. 2021 Oct;12(20):2811-2814. doi: 10.1111/1759-7714.14106. Epub 2021 Aug 17.
6
Drug-induced immune-mediated thrombocytopenia secondary to durvalumab use.使用度伐利尤单抗继发的药物诱导的免疫介导性血小板减少症。
Clin Case Rep. 2021 Jun 22;9(6):e04227. doi: 10.1002/ccr3.4227. eCollection 2021 Jun.
7
Lung adenocarcinoma initially presenting as Trousseau's syndrome treated successfully with pembrolizumab: A case report.肺腺癌初诊为特鲁索氏综合征，成功用帕博利珠单抗治疗：一例报告。
Thorac Cancer. 2021 Feb;12(4):557-559. doi: 10.1111/1759-7714.13794. Epub 2020 Dec 21.
8
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂所致血液学不良事件的诊断与管理：系统评价。
Front Immunol. 2020 Oct 21;11:1354. doi: 10.3389/fimmu.2020.01354. eCollection 2020.
9
Severe Thrombocytopenia Associated With Pembrolizumab in Patients With Non-small Cell Lung Cancer (NSCLC): A Case Report and Literature Review.帕博利珠单抗相关的非小细胞肺癌患者重度血小板减少症：病例报告及文献复习。
In Vivo. 2020 Mar-Apr;34(2):877-880. doi: 10.21873/invivo.11852.
10
Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia.免疫检查点抑制剂的血液学副作用：以免疫相关血小板减少症为例。
Front Pharmacol. 2019 Apr 26;10:454. doi: 10.3389/fphar.2019.00454. eCollection 2019.